The U.S. pilot research site, led by Principal Investigator Charles A. Nelson III,  is based at the Labs of Cognitive Neuroscience (LCN) at Boston Children’s Hospital, a primary teaching hospital of Harvard Medical School. Data will be collected over a period of two to five years from children aged 2 to 5 years in the United States, with recruitment focused on the greater Boston area.

The planned LEVANTE research will implement the LEVANTE Core Assessment Measures with a Boston‑based cohort of 200 children aged 2 to 5. The primary goal is to evaluate and refine the battery for younger children prior to broader international deployment. Children (n=50 per age group) will complete an initial assessment consisting of two lab visits, followed by two additional visits one year later.

Data collection will take place at the LCN, a large, child‑friendly research facility with extensive experience in recruiting and retaining diverse samples. Families will be recruited through community outreach, social media, and an established participant registry, with targeted efforts to enroll racial and ethnic minorities and reduce barriers to participation.

Read more about the LEVANTE Pilot Sites.

Professor Stella Yemisi Erinosho

Charles A. Nelson III

Principal Investigator

Charles A. Nelson III, is currently professor of pediatrics and neuroscience and professor of psychology in the Department of Psychiatry at Harvard Medical School, and professor of education in the Harvard Graduate School of Education. He also holds the Richard David Scott Chair in Pediatric Developmental Medicine Research at Boston Children’s Hospital, and serves as director of research in the Division of Developmental Medicine. His research interests center on a variety of problems in developmental cognitive neuroscience, including: the development of social perception; developmental trajectories to autism; and the effects of early adversity on brain and behavioral development.